Back to first-pass browser

First-pass extracted concept

safe harbor sites

Candidate: concept label1 source documents5 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

SHSs

Extracted Explainers

What the tool is doing

Safe harbor sites are genomic loci used for targeted insertion of exogenous DNA so that transgenes can be expressed reliably. The review frames them as insertion sites that should avoid disrupting endogenous gene function, genome integrity, or cellular physiology.

Source 1DOIPubMed

Resources required

Use of SHSs requires a targeted genome engineering approach and a chosen genomic locus that meets stated safety and functional criteria. The abstract also links modern SHS work to genome editing technologies and CRISPR-based validation.

Source 1DOIPubMed

What problem it solves

They address the instability and safety risks of random transgenesis, especially insertional mutagenesis and transcriptional dysregulation. They also help when multiple complementary insertion sites are needed.

Source 1DOIPubMed

What it does not solve

The review notes ongoing challenges in identifying universally applicable SHSs across biological systems. This implies that no single locus is guaranteed to work optimally in every context.

Source 1DOIPubMed

Alternatives

The abstract contrasts SHSs with traditional retroviral or lentiviral random integration approaches. It also contrasts older random-transgenesis-based discovery with newer genome-wide in silico screening followed by CRISPR-based validation.

Source 1DOIPubMed

Evidence Snippets

Safe harbor sites (SHSs), genomic loci that support reliable transgene expression without compromising endogenous gene function, genomic integrity, or cellular physiology
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1application scopesupports2026Source 1DOIPubMed

Human safe harbor sites are applied in basic research, gene therapy, CAR T cell-based therapy, and biotechnological production systems.

Claim 2definitionsupports2026Source 1DOIPubMed

Safe harbor sites are genomic loci that support reliable transgene expression without compromising endogenous gene function, genomic integrity, or cellular physiology.

Claim 3discovery strategy summarysupports2026Source 1DOIPubMed

The review identifies two primary strategies for discovering human safe harbor sites: lentiviral-based random transgenesis and genome-wide in silico screening followed by CRISPR-based validation.

Claim 4limitation summarysupports2026Source 1DOIPubMed

A major challenge is identifying universally applicable safe harbor sites and refining and validating them across biological systems.

Claim 5risk comparisonsupports2026Source 1DOIPubMed

Traditional retroviral transgenesis produces random genomic integration that poses risks of insertional mutagenesis and transcriptional dysregulation.